These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 18467075

  • 1. Real-time monitoring of phosphodiesterase inhibition in intact cells.
    Herget S, Lohse MJ, Nikolaev VO.
    Cell Signal; 2008 Aug; 20(8):1423-31. PubMed ID: 18467075
    [Abstract] [Full Text] [Related]

  • 2. Profiling of cAMP and cGMP phosphodiesterases in isolated ventricular cardiomyocytes from human hearts: comparison with rat and guinea pig.
    Johnson WB, Katugampola S, Able S, Napier C, Harding SE.
    Life Sci; 2012 Feb 27; 90(9-10):328-36. PubMed ID: 22261303
    [Abstract] [Full Text] [Related]

  • 3. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
    Rutten K, Prickaerts J, Hendrix M, van der Staay FJ, Sik A, Blokland A.
    Eur J Pharmacol; 2007 Mar 08; 558(1-3):107-12. PubMed ID: 17207788
    [Abstract] [Full Text] [Related]

  • 4. Compartmentalization of PDE-4 and cAMP-dependent protein kinase in neutrophils and macrophages during phagocytosis.
    Pryzwansky KB, Kidao S, Merricks EP.
    Cell Biochem Biophys; 1998 Mar 08; 28(2-3):251-75. PubMed ID: 9515168
    [Abstract] [Full Text] [Related]

  • 5. Phosphodiesterase inhibitors for the treatment of erectile dysfunction.
    Küthe A, Montorsi F, Andersson KE, Stief CG.
    Curr Opin Investig Drugs; 2002 Oct 08; 3(10):1489-95. PubMed ID: 12431025
    [Abstract] [Full Text] [Related]

  • 6. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M, Pekkinen M, Huttunen M, Lamberg-Allardt C.
    Cell Mol Biol Lett; 2005 Oct 08; 10(2):305-19. PubMed ID: 16010295
    [Abstract] [Full Text] [Related]

  • 7. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA, Ansink K, Vanschoonbeek K, Heemskerk JW.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1559-67. PubMed ID: 15041473
    [Abstract] [Full Text] [Related]

  • 8. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):110-7. PubMed ID: 16458289
    [Abstract] [Full Text] [Related]

  • 9. [Ultracytochemical localization of cyclic 3',5'-nucleotide phosphodiesterase activity in human term placenta].
    Matsubara S, Tamada T, Saito T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec 08; 39(12):2173-9. PubMed ID: 2828493
    [Abstract] [Full Text] [Related]

  • 10. Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
    Whalin ME, Scammell JG, Strada SJ, Thompson WJ.
    Mol Pharmacol; 1991 Jun 08; 39(6):711-7. PubMed ID: 1646946
    [Abstract] [Full Text] [Related]

  • 11. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
    de Vente J, Markerink-van Ittersum M, Vles JS.
    J Chem Neuroanat; 2006 Jun 08; 31(4):275-303. PubMed ID: 16621445
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC, Shih CM, Lai YH, Chen JH, Huang HL.
    Biochem Pharmacol; 2004 Nov 15; 68(10):2087-94. PubMed ID: 15476679
    [Abstract] [Full Text] [Related]

  • 13. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM, Brenna KJ, Colman RW, Sheth SB.
    Thromb Haemost; 2002 May 15; 87(5):873-9. PubMed ID: 12038792
    [Abstract] [Full Text] [Related]

  • 14. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3.
    Beierwaltes WH.
    Am J Physiol Renal Physiol; 2006 Jun 15; 290(6):F1376-81. PubMed ID: 16449359
    [Abstract] [Full Text] [Related]

  • 15. Phosphodiesterase 3 and 5 and cyclic nucleotide-gated ion channel expression in rat trigeminovascular system.
    Kruse LS, Sandholdt NT, Gammeltoft S, Olesen J, Kruuse C.
    Neurosci Lett; 2006 Aug 14; 404(1-2):202-7. PubMed ID: 16808996
    [Abstract] [Full Text] [Related]

  • 16. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Matsumori A, Ono K, Sato Y, Shioi T, Nose Y, Sasayama S.
    J Mol Cell Cardiol; 1996 Dec 14; 28(12):2491-9. PubMed ID: 9004165
    [Abstract] [Full Text] [Related]

  • 17. Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.
    Whalin ME, Garrett RL, Thompson WJ, Strada SJ.
    Second Messengers Phosphoproteins; 1996 Dec 14; 12(5-6):311-25. PubMed ID: 2856115
    [Abstract] [Full Text] [Related]

  • 18. Nitric oxide-induced changes in endothelial expression of phosphodiesterases 2, 3, and 5.
    Schankin CJ, Kruse LS, Reinisch VM, Jungmann S, Kristensen JC, Grau S, Ferrari U, Sinicina I, Goldbrunner R, Straube A, Kruuse C.
    Headache; 2010 Mar 14; 50(3):431-41. PubMed ID: 19751368
    [Abstract] [Full Text] [Related]

  • 19. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
    Dunkern TR, Hatzelmann A.
    Cell Signal; 2005 Mar 14; 17(3):331-9. PubMed ID: 15567064
    [Abstract] [Full Text] [Related]

  • 20. Optimization and validation of a reporter gene assay for screening of phosphodiesterase inhibitors in a high throughput system.
    Nanda K, Chatterjee M, Arya R, Mukherjee S, Saini KS, Dastidar S, Ray A.
    Biotechnol J; 2008 Oct 14; 3(9-10):1276-9. PubMed ID: 18655041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.